Degree | Department/Program | Institute | Year |
1993 | |||
1999 | |||
2004 | |||
2006 | |||
2012 |
1. ORAK HÜCRELİ HASTALARIN VE AİLELERİNİN RUHSAL VE SOSYAL DURUMLARININ DEĞERLENDİRİLMESİ , Supervisor: Dr. selma - ünal, Mersin University, Others, Other Department, mersin, Turkey, .
2019
2. KAYA, S.; ALAKAYA, M.; KORULMAZ, A.; ARSLANKÖYLÜ, A.; ESEN, K.; ÜNAL, S. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2019, 12, 557-560. 0 + 010.26559/mersinsbd.566658
2018
1. CEVHER, F.; ÜNAL, S.; KÜÇÜKKAVRUK, Ş.; TAŞDELEN, B.; TUNÇTAN, B. . TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2018, 38, 30-39. 0 + 010.5336/medsci.2017-57070
2020
82. SABUNCUOĞLU, S.; ER ÖZTAŞ, Y.; YALÇINKAYA, A.; ÜNAL, S.; BAYDAR, T.; GİRGİN, G. . ANNALS OF HEMATOLOGY, 2020, 99, 41-47. 550 + 010.1007/s00277-019-03817-5
81. Cappellini, M.; Viprakasit, V.; Taher, A.; Georgiev, P.; Kuo, K.; Coates, T.; Voskaridou, E.; Liew, H.; Pazgal-Kobrowski, I.; Forni, G. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. MASSACHUSETTS MEDICAL SOCIETY, 2020, 382, 1219-1231. 0 + 0http://dx.doi.org/10.1056/NEJMoa1910182
80. Rumeli Atıcı, Ş. Patient-controlled analgesia and morphine consumption in sickle cell anemia painful crises: A new protocol. KARE PUBLISHING, 2020, 0-0. 0 + 0http://dx.doi.org/10.14744/agri.2020.46354
79. SABUNCUOĞLU, S.; ER ÖZTAŞ, Y.; YALÇINKAYA, A.; ÜNAL, S.; BAYDAR, T.; GİRGİN, G. . ANNALS OF HEMATOLOGY, 2020, 99, 41-47. 550 + 010.1007/s00277-019-03817-5
78. Vatansever, E.; Vatansever, M.; Dinç, E.; Temel, G.; Ünal, S. Evaluation of Ocular Complications by Using Optical Coherence Tomography in Children With Sickle Cell Disease Eye Findings in Children With Sickle Cell Disease. OVID TECHNOLOGIES (WOLTERS KLUWER HEALTH), 2020, 42, 92-99. 500 + 0http://dx.doi.org/10.1097/MPH.0000000000001678
2019
77. ÜNAL, S. . EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102, 123-130. 1000 + 010.1111/ejh.13180
76. DANACI VATANSEVER, E.; VATANSEVER, M.; DİNÇ, E.; OREKİCİ TEMEL, G.; ÜNAL, S. . JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 2019, , 1-. 500 + 010.1097/MPH.0000000000001678
75. YALÇINKAYA, A.; samadi, a.; LAY, İ.; ÜNAL, S.; SABUNCUOĞLU, S.; ER ÖZTAŞ, Y. . SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION, 2019, 79, 381-387. 550 + 010.1080/00365513.2019.1627578
74. YALÇINKAYA, A.; Samadi, A.; LAY, İ.; ÜNAL, S.; SABUNCUOĞLU, S.; ER ÖZTAŞ, Y. . SCANDINAVIAN JOURNAL OF CLINICAL LABORATORY INVESTIGATION, 2019, 79, 381-387. 550 + 010.1080/00365513.2019.1627578
73. YALÇINKAYA, A.; ÜNAL, S.; ER ÖZTAŞ, Y. . LIPIDS IN HEALTH AND DISEASE, 2019, 18, -. 1000 + 010.1186/s12944-019-1174-5
72. vichinsky, E.; Hoppe, C.; Ataga, K.; Ware, R.; Nduba, V.; El Beslawy, V.; Hassab, H.; Achebe, M.; Alkindi, S.; ÜNAL, S. . N ENGL J MED, 2019, , -. 100 + 0
71. Vichinsky, E.; Hoppe, C.; Ataga, K.; Ware, R.; Nduba, V.; El-Beshlawy, A.; Hassab, H.; Achebe, M.; Alkindi, S.; Brown, R. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. MASSACHUSETTS MEDICAL SOCIETY, 2019, 381, 509-519. 0 + 0http://dx.doi.org/10.1056/NEJMoa1903212
2018
70. ÖZTÜRK TONGUÇ, M.; ÜNAL, S.; BOZDOĞAN ARPACI, R. . JOURNAL OF ORAL SCIENCE., 2018, , -. 1000 + 010.2334/josnusd.16-0796.
69. ÜNAL, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 1000 + 010.4274/tjh.2017.0039
68. ARIKOĞLU, T.; er, m.; ÜNAL, S.; yıldırım, d.; çıtak, f.; KUYUCU, N.; KUYUCU, S. . PEDIATRIC ALLERGY, IMMUNOLOGY, AND PULMONOLOGY, 2018, 31, 78-83. 600 + 010.1089/ped.2018.0870
67. BOZLU, G.; KARPUZ, D.; HALLIOĞLU KILINÇ, O.; ÜNAL, S.; KUYUCU, N. . CARDIOLOGY IN THE YOUNG, 2018, 28, 832-836. 600 + 010.1017/S1047951118000422
66. ARIKOĞLU, T.; ER, M.; ÜNAL, S.; DERİCİ YILDIRIM, D.; ERKASAR ÇİTAK, F.; KUYUCU, N.; KUYUCU, S. . PEDIATRIC ALLERGY, IMMUNOLOGY, AND PULMONOLOGY, 2018, 31, 78-83. 600 + 010.1089/ped.2018.0870
65. ÖZTÜRK TONGUÇ, M.; ÜNAL, S.; BOZDOĞAN ARPACI, R. . JOURNAL OF ORAL SCIENCE, 2018, 60, 105-114. 1000 + 010.2334/josnusd.16-0796
64. ÜNAL, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 1000 + 010.4274/tjh.2017.0039
63. türker, m.; tok, s.; ÖZGÜR, A.; ÜNAL, S.; zirek, s.; ESEN, K. . CURENT MEDICAL IMAGING REVIEWS, 2018, , -. 0 + 0
62. ÜNAL, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 1000 + 010.4274/tjh.2017.0039
61. ÜNAL, S.; KARAHAN, F.; ARIKOĞLU, T.; AKAR, A.; KUYUCU, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, , -. 900 + 010.4274/tjh.2018.0230
60. ER ÖZTAŞ, Y.; ÜNAL, S.; ESKANDARİ, H.; TAMER, L.; Özgüneş, N. . INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34, 480-485. 800 + 010.1007/s12288-017-0890-0
59. ÜNAL, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 1000 + 010.4274/tjh.2017.0039
58. ÜNAL, S.; KARAHAN, F.; arikoğlu, T.; AKAR, A.; KUYUCU, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, , -. 900 + 010.4274/tjh.2018.0230
57. BOZLU, G.; KARPUZ, D.; HALLIOĞLU KILINÇ, O.; ÜNAL, S.; KUYUCU, N. . CARDIOLOGY IN THE YOUNG, 2018, , 1-5. 600 + 010.1017/S1047951118000422
56. BOZLU, G.; KARPUZ, D.; HALLIOĞLU KILINÇ, O.; ÜNAL, S.; KUYUCU, N. . CARDIOLOGY IN THE YOUNG, 2018, 28, 832-836. 600 + 010.1017/S1047951118000422
55. ÜNAL, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, , -. 1000 + 0
2017
54. SÜRMELİ DÖVEN, S.; DELİBAŞ, A.; KAYACAN, U.; ÜNAL, S. . PEDIATRICS INTERNATIONAL, 2017, 59, 1178-1182. 650 + 010.1111/ped.13416
53. Karpuz, D.; Giray, D.; Ozyurt, A.; Bozlu, G.; Unal, S.; Hallioglu, O. Can whole-blood parameters be used in follow-up of children with rheumatic valvular heart disease?. CAMBRIDGE UNIVERSITY PRESS (CUP), 2017, 27, 764-769. 450 + 0http://dx.doi.org/10.1017/S1047951116001281
52. SUNDU, C.; DİNÇ, E.; SARI, A.; ÜNAL, S.; DURSUN, Ö. . JOURNAL OF CRANIOFACIAL SURGERY, 2017, 28, 775-776. 0 + 010.1097/SCS.0000000000003972
51. Sürmeli Döven, S.; Delibaş, A.; Kayacan, U.; Ünal, S. Short-cut diagnostic tool in cystinosis: Bone marrow aspiration. WILEY-BLACKWELL, 2017, 59, 1178-1182. 650 + 0http://dx.doi.org/10.1111/ped.13416
Publications_009.pdf
50. Aydınok, Y.; Oymak, Y.; Atabay, B.; Aydoğan, G.; Yesilipek, A.; Ünal, S.; Kılınç, Y.; Oflaz, B.; Akın, M.; Vergin, C. A national registry of thalassemia in Turkey; demographic and disease characteristics of patients, achievements and challenges in prevention. GALENOS YAYINEVI, 2017, 2-10. 150 + 0http://dx.doi.org/10.4274/tjh.2017.0039
49. Sundu, C.; Dinç, E.; Sari, A.; Ünal, S.; Dursun, Ö. Bilateral Subperiosteal Hematoma and Orbital Compression Syndrome in Sickle Cell Disease. OVID TECHNOLOGIES (WOLTERS KLUWER HEALTH), 2017, 28, 2-10. 600 + 0http://dx.doi.org/10.1097/SCS.0000000000003972
Publications_008.pdf
48. KARPUZ, D.; GİRAY, D.; Ozyurt, A.; BOZLU, G.; ÜNAL, S.; HALLIOĞLU KILINÇ, O. . CARDIOLOGY IN THE YOUNG, 2017, 27, 764-769. 450 + 010.1017/S1047951116001281
47. KARPUZ, D.; GİRAY, D.; ÖZYURT, A.; BOZLU, G.; ÜNAL, S.; HALLIOĞLU KILINÇ, O. . CARDIOLOGY IN THE YOUNG, 2017, 27, 764-769. 450 + 010.1017/S1047951116001281
46. Oztas, Y.; Unal, S.; Eskandari, G.; Tamer, L.; Ozgunes, N. Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients. SPRINGER NATURE, 2017, 0-0. 800 + 0http://dx.doi.org/10.1007/s12288-017-0890-0
2016
45. Tunctan, B.; Senol, S.; Tiftik, E.; Unal, S.; Akdeniz, A.; Tasdelen, B. Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy. MEDKNOW, 2016, 7, 49-49. 550 + 0http://dx.doi.org/10.4103/0976-0105.177706
Publications_005.pdf
44. Kebudi, R.; Bayram, I.; Yagci-Kupeli, B.; Kupeli, S.; Sezgin, G.; Pekpak, E.; Oymak, Y.; Ince, D.; Emir, S.; Tugcu, D. Refugee children with cancer in Turkey. ELSEVIER BV, 2016, 17, 865-867. 0 + 0http://dx.doi.org/10.1016/S1470-2045(16)30211-X
Publications_003.pdf
43. Heeney, M.; Hoppe, C.; Abboud, M.; Inusa, B.; Kanter, J.; Ogutu, B.; Brown, P.; Heath, L.; Jakubowski, J.; Zhou, C. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. NEW ENGLAND JOURNAL OF MEDICINE (NEJM/MMS), 2016, 374, 625-635. 0 + 0http://dx.doi.org/10.1056/NEJMoa1512021
Publications_006.pdf
42. Karacaoglu, P.; Asma, S.; Korur, A.; Solmaz, S.; Buyukkurt, N.; Gereklioglu, C.; Kasar, M.; Ozbalcı, D.; Unal, S.; Kaya, H. East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. SPRINGER NATURE, 2016, 95, 993-1000. 100 + 0http://dx.doi.org/10.1007/s00277-016-2655-5
Publications_004.pdf
41. Ünal, S.; Oktay, G.; Acıpayam, C.; İlhan, G.; Gali, E.; Celkan, T.; Bay, A.; Malbora, B.; Akar, N.; Oymak, Y. Hemoglobin H Disease in Turkey: Experience from Eight Centers. JOURNAL OF CLINICAL RESEARCH OF PEDIATRIC ENDOCRINOLOGY, 2016, 33, 56-59. 650 + 0http://dx.doi.org/10.4274/tjh.2014.0461
Publications_007.pdf
40. Bozlu, G.; Taskinlar, H.; Unal, S.; Alakaya, M.; Nayci, A.; Kuyucu, N. Diagnostic value of red blood cell distribution width in pediatric acute appendicitis. WILEY-BLACKWELL, 2016, 58, 202-205. 650 + 0http://dx.doi.org/10.1111/ped.12805
2015
39. Ozgunes, N.; Oztas, Y.; Unal, S.; Yaman, H. Structural Modification of Plasma Albumin in Sickle Cell Anemia. ACTA HAEMATOLOGICA, 2015, 133, 67-69. 750 + 0https://dx.doi.org/10.1159/000362860
38. Unal, S.; Ozdemir, O.; Ozcimen, A.; Oztas, Y. Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101, 114-118. 950 + 0https://dx.doi.org/10.1007/s12185-014-1718-4
37. Unal, S.; Kotan, C.; Delibas, A.; Oztas, Y. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32, 250-257. 950 + 0https://dx.doi.org/10.3109/08880018.2013.810317
2014
36. Ozcimen, A.; Unal, S.; Canacankatan, N.; Antmen, S. Tumor Necrosis Factor-Superfamily 15 Gene Expression in Patients with Sickle Cell Disease. TURKISH JOURNAL OF HEMATOLOGY, 2014, 31, 255-260. 850 + 0https://dx.doi.org/10.4274/tjh.2012.0130
35. Unal, S.; Oztas, Y.; Eskandari, G.; Gumus, L.; Nuriman, O. The Association Between Vitamin D and Inflammation in Sickle Cell Disease. BLOOD, 2014, 124, 0-0. 900 + 0
34. Komur, M.; Unal, S.; Okuyaz, C.; Ozgur, A. Moyamoya syndrome associated with sickle cell trait in a child. BRAIN & DEVELOPMENT, 2014, 36, 545-547. 850 + 0https://dx.doi.org/10.1016/j.braindev.2013.07.010
33. Unal, S.; Tezol, O.; Oztas, Y. A novel mutation of the transcobalamin II gene in an infant presenting with hemophagocytic lymphohistiocytosis. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99, 659-662. 1000 + 0https://dx.doi.org/10.1007/s12185-014-1545-7
32. Unal, S.; Balta, G.; Gumruk, F. Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study. TURKISH JOURNAL OF HEMATOLOGY, 2014, 31, 272-275. 1000 + 0https://dx.doi.org/10.4274/tjh.2012.0081
31. ÜNAL, S.; TEZOL, Ö.; ER ÖZTAŞ, Y. . INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, , -. 0 + 0
2013
30. Ozen, S.; Unal, S.; Ercetin, N.; Tasdelen, B. Frequency and Risk Factors of Endocrine Complications in Turkish Children and Adolescents with Sickle Cell Anemia. TURKISH JOURNAL OF HEMATOLOGY, 2013, 30, 25-31. 850 + 5https://dx.doi.org/10.4274/tjh.2012.0001
Times Cited: 1
2012
29. Unal, S.; Arslankoylu, A.; Kuyucu, N.; Aslan, G.; Erdogan, S. Procalcitonin is More Useful Than C-reactive Protein in Differentiation of Fever in Patients With Sickle Cell Disease. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34, 85-89. 900 + 15https://dx.doi.org/10.1097/MPH.0b013e3182495573
Times Cited: 3
28. Antmen, B.; Karakas, Z.; Oktay, G.; Akin, M.; Aydogan, G.; Salcioglu, Z.; Vergin, C.; Unal, S.; Organ, K.; Canatar, A. Reachthem: Baseline Characteristics of a 3 Year Prospective Registry of Children with Hemoglobinopathies Receiving Oral Iron Chelators in the Treatment of Transfusional Iron Overload. BLOOD, 2012, 120, 0-0. 100 + 0
27. ÜNAL, S.; ARSLANKÖYLÜ, A.; KUYUCU, N.; arslan, g.; ERDOĞAN, S. . PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, , -. 900 + 0
2011
26. Unal, S.; Toros, F.; Kutuk, M.; Uyaniker, M. Evaluation of the Psychological Problems in Children with Sickle Cell Anemia and Their Families. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28, 321-328. 950 + 35https://dx.doi.org/10.3109/08880018.2010.540735
Times Cited: 7
2010
25. Balta, G.; Okur, H.; Unal, S.; Yarali, N.; Gunes, A.; Unal, S.; Turker, M.; Gulerf, E.; Ertem, M.; Albayrak, M. Assessment of clinical and laboratory presentations of familial hemophagocytic lymphohistiocytosis patients with homozygous W374X mutation. LEUKEMIA RESEARCH, 2010, 34, 1012-1017. 450 + 30https://dx.doi.org/10.1016/j.leukres.2010.02.002
Times Cited: 6
24. Sari, A.; Erkayhan, G.; Unal, S.; Adiguzel, U. Orbital mass as a presenting sign of acute leukemia. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2010, 45, 188-189. 750 + 0https://dx.doi.org/10.3129/i09-206
23. Oztas, Y.; Tokgoz, I.; Unal, S.; Ozgunes, N. Comparison of Copper, Zinc, Iron and Calcium Levels in Plasma and Hemolysate of Steady State Sickle Cell Anemia Patients with Carriers. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2010, 35, 203-207. 750 + 0
2009
22. Oztas, Y.; Unal, S.; Ozgunes, N. Plasma Protein Oxidation and Triglyceride Levels in Sickle Cell Anemia. BLOOD, 2009, 114, 1012-1012. 1000 + 0
2008
21. Unal, S.; Gumruk, F.; Aytac, S.; Yalnzoglu, D.; Gurgey, A. Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) levels and IL-6, TNF-polymorphisms in children with thrombosis.. JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 2008, 30, 26-31. 900 + 30https://dx.doi.org/10.1097/MPH.0b013e31815b1a89
Times Cited: 6
20. Gumruk, F.; Tavil, B.; Balta, G.; Unal, S.; Gurgey, A. Significance of Fetal Hemoglobin Values in Detection of Heterozygotes in Fanconi Anemia Reevaluation of Fetal Hemoglobin Values by a Sensitive Method. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30, 896-899. 600 + 15
Times Cited: 3
2007
19. Tekcicek, M.; Tavil, B.; Cakar, A.; Pinar, A.; Unal, S.; Gumruk, F. Oral and dental findings in children with fanconi anemia. PEDIATRIC DENTISTRY, 2007, 29, 248-252. 450 + 5
Times Cited: 1
18. Yalcin, S.; Durmusoglu-Sendogdu, M.; Guemruek, F.; Unal, S.; Kargi, E.; Tugrul, B. Evaluation of the children with beta-thalassemia in terms of their self-concept, behavioral, and parental attitudes. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29, 523-528. 550 + 10
Times Cited: 2
17. Yalcin, S.; Uenal, S.; Guemruek, F.; Yurdakoek, K. The validity of pallor as a clinical sign of anemia in cases with beta-thalassemia. TURKISH JOURNAL OF PEDIATRICS, 2007, 49, 408-412. 0 + 0
16. ÜNAL, S.; YALÇIN, S.; GÜMRÜK, F.; YURDAKÖK, K. . TURKISH JOURMAL OF PEDIATRICS, 2007, , -. 950 + 0
2006
15. Ozyurek, E.; Ergunay, K.; Kuskonmaz, B.; Unal, S.; Cetin, M.; Ustacelebi, S.; Gurgey, A.; Gumruk, F. Transfusion-transmitted virus prevalance in Turkish patients with thalassemia. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23, 347-353. 450 + 25https://dx.doi.org/10.1080/08880010600631995
Times Cited: 5
2005
14. Yetgin, S.; Demir, H.; Arslan, D.; Unal, S.; Kocak, N. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection effectivity during childhood. AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78, 318-318. 600 + 60https://dx.doi.org/10.1002/ajh.20302
Times Cited: 12
13. Unal, S.; Gumruk, F.; Cetin, M.; Hicsonmez, G. Genital ulcers after treatment with all-trans-retinoic acid in a child with acute promyelocytic leukemia. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22, 357-359. 950 + 10https://dx.doi.org/10.1080/08880010590964138
Times Cited: 2
12. Gurgey, A.; Unal, S.; Okur, H.; Duru, F.; Gumruk, F. Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22, 309-314. 800 + 45https://dx.doi.org/10.1080/08880010590935202
Times Cited: 9
11. Unal, S.; Varan, A.; Yalcin, B.; Buyukpamukcu, M.; Gurgey, A. Evaluation of thrombotic children with malignancy. ANNALS OF HEMATOLOGY, 2005, 84, 395-399. 900 + 75https://dx.doi.org/10.1007/s00277-005-1004-x
Times Cited: 15
10. ÜNAL, S.; VARAN, A.; YALÇIN, B.; aytemiz, g. . ANNALS OF HEMATOLOGY, 2005, , -. 950 + 0
2004
9. Unal, S.; Ozbek, N.; Kara, A.; Alikasifoglu, M.; Gumruk, F. Five Fanconi anemia patients with unusual organ pathologies. AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77, 50-54. 900 + 10https://dx.doi.org/10.1002/ajh.20130
Times Cited: 2
8. KUYUCU, S.; ÜNAL, S.; KUYUCU, N.; yılgör, e. . PEDIATRICS INTERNATIONAL, 2004, , -. 850 + 0
7. Unal, S.; Yetgin, S.; Cetin, M.; Gumruk, F.; Arslan, D.; Ozyurek, E.; Tuncer, M.; Topcu, M. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2004, 21, 279-289. 750 + 30https://dx.doi.org/10.1080/08880010490277097
Times Cited: 6
6. Kuyucu, S.; Unal, S.; Kuyucu, N.; Yilgor, E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. PEDIATRICS INTERNATIONAL, 2004, 46, 539-544. 850 + 90https://dx.doi.org/10.1111/j.1442-200x.2004.01944.x
Times Cited: 18
5. Hicsonmez, G.; Cetin, M.; Tuncer, A.; Yenicesu, I.; Aslan, D.; Ozyurek, E.; Unal, S. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment. LEUKEMIA RESEARCH, 2004, 28, 25-34. 200 + 85https://dx.doi.org/10.1016/S0145-2126(03)00159-0
Times Cited: 17
4. Toksoz, H.; Unal, S.; Kirazli, S.; Gurgey, A. The effect of short course high dose methylprednisolon therapy on fibrinogen level in children with acute lymphoblastic leukemia - A preliminary study. LEUKEMIA RESEARCH, 2004, 28, 533-535. 850 + 15https://dx.doi.org/10.1016/j.leukres.2003.09.012
Times Cited: 3
3. Unal, S.; Balta, G.; Duru, F.; Gumruk, F.; Altay, C.; Gurgey, A. Clinical and laboratory evaluation of Turkish children with thrombosis for homozygous factor V G1691A mutation. BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15, 343-346. 850 + 15https://dx.doi.org/10.1097/01.mbc.0000114417.81125.70
Times Cited: 3
2003
2. Caglar, K.; Unal, S.; Cetinkaya, A.; Gumruk, F.; Yetgin, S. Acute lymphoblastic leukemia as a second malignant neoplasm in a child with medulloblastoma. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, 20, 535-537. 800 + 20https://dx.doi.org/10.1080/08880010390232745
Times Cited: 4
1. çağlar, k.; ÜNAL, S.; çetinkaya, a.; GÜMRÜK, F.; yetgin, s. . PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, , -. 0 + 0
2018
2. ÜNAL, S. . TURKISH JOURNAL OF HEMATOLOGY, 2018, 35, 12-18. 100 + 010.4274/tjh.2017.0039
1. CEVHER, F.; ÜNAL, S.; KÜÇÜKKAVRUK, Ş.; TAŞDELEN, B.; TUNÇTAN, B. . TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES, 2018, 38, 30-39. 80 + 010.5336/medsci.2017-57070
2017
1. İSBİR, C.; BAHADIR, G.; TAŞKINLAR, H.; KILLI, İ.; AKYOL, T.; ÇITAK, E.; ÜNAL, S.; NAYCI, A. . JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2017, , 1-4. 48 + 010.4328/JCAM.5039
2020
5. döven, s. Determination of the Frequency of Sickle Cell Trait in the Patients with Chronic Kidney Diseases. BALIKESIR MEDICAL JOURNA, 2020, 4, 55-59. 0 + 0
4. alakaya, m. Recurrent Ischemic Stroke in A Child with Thiamine Responsive Megaloblastic Anemia Syndrome. FIRAT TIP DERGISI, 2020, 25, 105-107. 0 + 0
2019
3. ÜNAL, S.; KARAHAN, F. . TURKIYE KLINIKLERI, 2019, , -. 200 + 0
2017
2. cevher, f.; pınar, k.; ünal, s.; taşdelen, b.; tunçtan, b. Quality of life, clinical effectiveness, and satisfaction in pediatric and young adult patients with sickle cell disease receiving hydroxyurea therapy. TURKIYE KLINIKLERI, 2017, 3, 1-3. 140 + 0
1. ahmet, y.; inci, l.; Samadi, A.; selma, ü.; akbıyık, f.; öztaş, y. Hypocholesterolemia and Increased Plasma 7-ketocholesterol Levels in Pediatric Sickle Cell Patients. ACTA MEDICA, 2017, 6, 1-3. 0 + 0
2018
2. KARAHAN, F.; KOZANOĞLU İNCE, B.; ULUKÖKSAL, U.; KARACAY, O.; TÜRKEGÜN, M.; ÜNAL, S. . MERSIN UNIV SAGLIK BILIM DERG, 2018, 11, 219-225. 40 + 0
2017
1. YALÇINKAYA, A.; LAY, İ.; Samadi, A.; ÜNAL, S.; AKBIYIK, F.; ER ÖZTAŞ, Y. . ACTA MEDICA, 2017, 48, 1-4. 55 + 0
1. İŞBİR, C.; BAHADIR, G.; TAŞKINLAR, H.; KILLI, İ.; CAN AKYOL, T.; ÇITAK, E.; ÜNAL, S.; NAYCI, A. . JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2017, , -. 16 + 0
1. AYDINOK, Y.; ÜNAL, S. YURDAKÖK PEDİATRİ, ISBN: , GÜNEŞ TIP KİRAPEVİ, Number of print: 1, Total Printing Number: , Page, Turkish, , Turkey, 2017. 0
2. ÜNAL, S.; GÜMRÜK, F.; YENİCESU, İ.; YARALI, N.; ÜNAL CANGÜL, Ş.; AKARSU, S.; İLERİ, D.; PATIROĞLU, T.; BENGO A YILMAZ, Ş. HEMATOLOG, ISBN: , gALENOS YAYINEVİ, Number of print: 1, Total Printing Number: , Page, Turkish, , Turkey, 2017. 0
3. ÜNAL, S.; SAYINALP, N.; AYDINOK, Y.; YAMAN BAJİN, H.; ÜNAL CANGÜL, Ş.; GÜMRÜK, F.; KUŞKONMAZ, B.; TİFTİK, E. Talsemi Hasta Kılavuzu, ISBN: , THD, Number of print: 1, Total Printing Number: , 66 Page, Turkish, Ankara, Turkey, 2017. 0
4. AYDINOK, Y.; ÜNAL, S. Yurdakök Pediatri, ISBN: 9789752776630, Güneş Kitabevi, Number of print: 1, Total Printing Number: , 5672 Page, Turkish, Ankara, Turkey, 2017. 0
5. ünal , s. Newborn hematology, ISBN: 2528-9756, Galenos, Number of print: 1, Total Printing Number: 300, 161 Page, Turkish, istanbul, Turkey, 2016. 0
1. Yalçınkaya, A., Increased plasma 7-ketocholesterol levels may explain the hypocholesterolemia of sickle cell disease patients. 41st FEBS kongress, 2016-09-03, 2016-09-08, Kuşadası, Turkey, 2016. 0
1. yalçınkaya, A., Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease. . 59th American Society of Hematology Annual Meeting & Exposition, 2017-12-09, 2017-12-12, Atlanta, United States of America, 2017. 0
1. Girgin, G., Altered neopterin levels in sickle cell anemia. 36th International Winter-Workshop Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics, 2017-02-21, 2017-02-24, Innsbruck, Austria, 2017. 0
1. Öztürk, M.; Ünal, S.; Babuşoğlu, O.; Polat, G.; Soyadı, A.; Soyadı, A.; Soyadı, A., The reletainonship between serum YKL-40 acute pahase protein and salivary citokine levels in children . CEDIADR 2015, 2015-10-17, 2015-10-19, Antalya, Turkey, 2015. 27
http://ced-iadr2015.com/
1. A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Phase Iıb Study To Evaluate The Effect Of Ticagrelor 10 Mg And 45 Mg Bid Versus Placebo İn Reducing The Number Of Days With Pain İn Young Adults With Sickle Cell Disease, , Project Number: 003, 0 TL, Researcher, 2017,Completed. 0
2. , BAP, Project Number: , EUR, Manager, 2017,Completed. 100
1. Relationship between YKL-40 and others markers in stable and vaso-occlusive crises state of Sickle Cell Anemia child., BAP, Project Number: 2016-2-TP3-1892, 7797 TL, Manager, 2017,Completed. 100
8. Evaluation of the Relationship Between Complications of Mouth-Tooth and Jaw Bone and Endodontic Condition with Hematological Findings and Systemic Inflammation in Children with Sickle Cell Disease, BAP, Project Number: 2019-3-AP5-3803, 47450 TL, Researcher, Continue... 50
7. , BAP, Project Number: , 105000 TL, Researcher, Continue... 50
6. Investigation of SOCS-1 Gene Polymorphism from Cytokine Signal Suppressors (SOCS Protein Family) in Sickle Cell Disease, BAP, Project Number: 2017-2-AP2-2538, 15000 TL, Researcher, 2018,Completed. 50
5. Inverstigation of HMIP-2 , BCL11a and Beta globin locus polymorphismis affecting the HbF level i Sicle Cell patients and carriers, BAP, Project Number: 2016-1-AP4-1411, 30000 TL, Researcher, 2017,Completed. 50
4. , BAP, Project Number: , 30000 TL, Researcher, 2017,Completed. 50
3. -Orak hücre hastalığı ve Astım Paradigması: Arginin metabolizmasındaki bozuklukların astım benzeri akciğer hastalığı gelişimindeki rolü, TÜBİTAK, Project Number: 215S154, 0 TL, Researcher, 2017,Completed. 50
2. The research of HMIP-2(rs9399137-rs9402685-rs11759553) locus of polymorphism which affects the level of HbF insickle cell patients, BAP, Project Number: 2016-1-TP2-1410, 11000 TL, Researcher, 2017,Completed. 50
1. Determining the prevalence of respiratory allergic diseases in children with sickle cell anemia and to investigate the relationship between nitric oxide in exhaled air, BAP, Project Number: 2015-TP3-1283, 14100 TL, Researcher, 2016,Completed. 50
3. Nazım Yıldırım, orak hücre hastalığında eritrositlerin intravasküler hemolizi ile klinik bulgular arasındaki ilişkinin incelenmesi, Others, Others, Continue. 0
2. Veysi Akbey, ORAK HÜCRE ANEMİSİ OLAN ÇOCUKLARDA KARARLI DURUM VE KRİZ DÖNEMLERİNDE SERUM YKL40 İLE DİĞER İNFLAMATUAR BELİRTEÇLER ARASINDAKİ İLİŞKİ, Others, Others, Continue. 0
1. Esra Vatansever, , Others, Others, Continue. 400